February 2, 2024 · Form 4 insider transaction
Sims Karen sold 4,358 shares of ARBUTUS BIOPHARMA CORP at $2.31 per share, a transaction worth $10.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 9, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of a previous grant of restricted stock units.